Laidlaw Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$4.88M Buy
52,387
+730
+1% +$68.1K 2.32% 17
2015
Q1
$4.89M Buy
51,657
+25
+0% +$2.32K 2.33% 18
2014
Q4
$4.58M Buy
51,632
+262
+0.5% +$22.2K 2.18% 18
2014
Q3
$4.11M Sell
51,370
-270
-0.5% -$20.3K 2.04% 20
2014
Q2
$3.66M Buy
51,640
+1,315
+3% +$92.6K 1.82% 25
2014
Q1
$3.73M Buy
50,325
+1,990
+4% +$150K 1.95% 21
2013
Q4
$3.79M Buy
48,335
+320
+0.7% +$25.1K 2.03% 15
2013
Q3
$3.55M Sell
48,015
-1,378
-3% -$102K 2.03% 17
2013
Q2
$3.75M Buy
+49,393
New +$3.24M 2.12% 15

Other funds holding CME

Laidlaw Group's CME Position: Q2 2015 in Review

Laidlaw Group increased its CME Group (CME) stake by 1.4% in Q2 2015, buying an estimated $68.1K and bringing the position to 52,387 shares worth $4.88M. The position accounts for 2.32% of the portfolio, ranked #17.

Laidlaw Group first reported a position in CME in Q2 2013 and has held it in 9 quarters since. The position peaked at $4.89M in Q1 2015. 608 funds tracked by Wall St. Rank hold CME as of Q2 2015.

  • Laidlaw Group held 52,387 shares of CME Group worth $4.88M as of Q2 2015.
  • Laidlaw Group bought 730 CME Group shares in Q2 2015, an estimated $68.1K.
  • CME Group made up 2.32% of Laidlaw Group's portfolio in Q2 2015, its #17 holding.
  • Laidlaw Group first reported a position in CME Group in Q2 2013 and has held it in 9 quarters since.
  • Laidlaw Group's CME Group position peaked at $4.89M in Q1 2015.
  • 608 funds tracked by Wall St. Rank held CME Group as of Q2 2015.

Based on Laidlaw Group's 13F filing for Q2 2015, filed 31 Jul 2015.